Answers are grounded in this paper and cite their sources.
A simple, sensitive, accurate and precise RP-HPLC method was developed for the simultaneous determination of Remogliflozin and Teneligliptin in pure and pharmaceutical dosage form. The components were separated on Agilent Eclipse XDB C18 column (1504.6 mm,3.5 ) using the mobile phase composed of acetonitrile and 0.1% TFA (65:35, v/v). The response was detected at 225nm. The peaks of Remogliflozin and Teneligliptin were retained at 3.25 min and 3.87 min respectively. The optimized method was validated as per ICH recommendations. The developed method produced linear response in the range of 25-150 g/mL for Remogliflozin and 2.5-15 g/mL for Teneligliptin with a good correlation coefficient. Low % RSD values and excellent recoveries demonstrated the precision and accuracy of the method. The limits of detection for Remogliflozin and Teneligliptin were 3 and 0.3 g/ml, while the limits of quantification were 10 and 1 g/ml respectively. Stability studies were carried out under acidic, alkaline, oxidative, photolytic and thermal conditions and no significant degradation was observed. The proposed method was so rapid, precise and economical that can be applied successfully for simultaneous estimation of both Remogliflozin and Teneligliptin in bulk and combined tablet formulation.
No takes yet. Share an insight, caveat, or question.
Prasanthi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: